These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
253 related articles for article (PubMed ID: 18329692)
1. Histopathologic factors significantly associated with initial organ-specific metastasis by invasive ductal carcinoma of the breast: a prospective study. Hasebe T; Imoto S; Yokose T; Ishii G; Iwasaki M; Wada N Hum Pathol; 2008 May; 39(5):681-93. PubMed ID: 18329692 [TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of fibrotic focus in invasive ductal carcinoma of the breast: a prospective observational study. Hasebe T; Sasaki S; Imoto S; Mukai K; Yokose T; Ochiai A Mod Pathol; 2002 May; 15(5):502-16. PubMed ID: 12011255 [TBL] [Abstract][Full Text] [Related]
3. Risk factors for initial lung metastasis from breast invasive ductal carcinoma in stages I-III of operable patients. Gao D; Du J; Cong L; Liu Q Jpn J Clin Oncol; 2009 Feb; 39(2):97-104. PubMed ID: 19052036 [TBL] [Abstract][Full Text] [Related]
4. Grading system for lymph vessel tumor emboli for prediction of the outcome of invasive ductal carcinoma of the breast. Hasebe T; Yamauchi C; Iwasaki M; Ishii G; Wada N; Imoto S Hum Pathol; 2008 Mar; 39(3):427-36. PubMed ID: 18261627 [TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of mitotic figures in metastatic mammary ductal carcinoma to the lymph nodes. Hasebe T; Iwasaki M; Akashi-Tanaka S; Hojo T; Shibata T; Sasajima Y; Kinoshita T; Tsuda H Hum Pathol; 2011 Dec; 42(12):1823-32. PubMed ID: 21683981 [TBL] [Abstract][Full Text] [Related]
6. Multivariate prognostic evaluation of the mitotic activity index and fibrotic focus in node-negative invasive breast cancers. Baak JP; Colpaert CG; van Diest PJ; Janssen E; van Diermen B; Albernaz E; Vermeulen PB; Van Marck EA Eur J Cancer; 2005 Sep; 41(14):2093-101. PubMed ID: 16153819 [TBL] [Abstract][Full Text] [Related]
7. A retrospective review with long term follow up of 11,400 cases of pure mucinous breast carcinoma. Di Saverio S; Gutierrez J; Avisar E Breast Cancer Res Treat; 2008 Oct; 111(3):541-7. PubMed ID: 18026874 [TBL] [Abstract][Full Text] [Related]
8. Highly proliferative fibroblasts forming fibrotic focus govern metastasis of invasive ductal carcinoma of the breast. Hasebe T; Sasaki S; Imoto S; Ochiai A Mod Pathol; 2001 Apr; 14(4):325-37. PubMed ID: 11301349 [TBL] [Abstract][Full Text] [Related]
9. Grading system for lymph vessel tumor emboli: significant outcome predictor for invasive ductal carcinoma of the breast. Hasebe T; Okada N; Iwasaki M; Akashi-Tanaka S; Hojo T; Shibata T; Sasajima Y; Tsuda H; Kinoshita T Hum Pathol; 2010 May; 41(5):706-15. PubMed ID: 20060154 [TBL] [Abstract][Full Text] [Related]
10. Important histologic outcome predictors for patients with invasive ductal carcinoma of the breast. Hasebe T; Iwasaki M; Akashi-Tanaka S; Hojo T; Shibata T; Kinoshita T; Tsuda H Am J Surg Pathol; 2011 Oct; 35(10):1484-97. PubMed ID: 21881484 [TBL] [Abstract][Full Text] [Related]
11. Characteristics of tumors in lymph vessels play an important role in the tumor progression of invasive ductal carcinoma of the breast: a prospective study. Hasebe T; Sasaki S; Imoto S; Ochiai A Mod Pathol; 2002 Sep; 15(9):904-13. PubMed ID: 12218207 [TBL] [Abstract][Full Text] [Related]
12. Atypical tumor-stromal fibroblasts in invasive ductal carcinoma of the breast. Hasebe T; Iwasaki M; Akashi-Tanaka S; Hojo T; Shibata T; Sasajima Y; Kinoshita T; Tsuda H Am J Surg Pathol; 2011 Mar; 35(3):325-36. PubMed ID: 21317705 [TBL] [Abstract][Full Text] [Related]
13. Extensive retraction artifact correlates with lymphatic invasion and nodal metastasis and predicts poor outcome in early stage breast carcinoma. Acs G; Dumoff KL; Solin LJ; Pasha T; Xu X; Zhang PJ Am J Surg Pathol; 2007 Jan; 31(1):129-40. PubMed ID: 17197929 [TBL] [Abstract][Full Text] [Related]
14. Metaplastic carcinoma of the breast. Okada N; Hasebe T; Iwasaki M; Tamura N; Akashi-Tanaka S; Hojo T; Shibata T; Sasajima Y; Kanai Y; Kinoshita T Hum Pathol; 2010 Jul; 41(7):960-70. PubMed ID: 20236684 [TBL] [Abstract][Full Text] [Related]
15. A proposal for a new histological classification scheme for predicting short-term tumor recurrence and death in patients with invasive ductal carcinoma of the breast. Hasebe T; Imoto S; Sasaki S; Mukai K Jpn J Cancer Res; 1998 Dec; 89(12):1358-73. PubMed ID: 10081498 [TBL] [Abstract][Full Text] [Related]
16. Is survival from infiltrating lobular carcinoma of the breast different from that of infiltrating ductal carcinoma? Jayasinghe UW; Bilous AM; Boyages J Breast J; 2007; 13(5):479-85. PubMed ID: 17760669 [TBL] [Abstract][Full Text] [Related]
17. Clinical-pathologic features and long-term outcomes of tubular carcinoma of the breast compared with invasive ductal carcinoma treated with breast conservation therapy. Liu GF; Yang Q; Haffty BG; Moran MS Int J Radiat Oncol Biol Phys; 2009 Dec; 75(5):1304-8. PubMed ID: 19386432 [TBL] [Abstract][Full Text] [Related]
18. How important is the axillary nodal status for adjuvant treatment decisions at a breast cancer multidisciplinary tumor board? A survival analysis. Reimer T; Fietkau R; Markmann S; Stachs A; Gerber B Ann Surg Oncol; 2008 Feb; 15(2):472-7. PubMed ID: 17987339 [TBL] [Abstract][Full Text] [Related]
19. Distant metastatic breast cancer as an incurable disease: a tenet with a need for revision. Güth U; Huang DJ; Dirnhofer S; Rochlitz C; Wight E Cancer J; 2009; 15(1):81-6. PubMed ID: 19197181 [TBL] [Abstract][Full Text] [Related]
20. Optimizing microvessel counts according to tumor zone in invasive ductal carcinoma of the breast. Jitsuiki Y; Hasebe T; Tsuda H; Imoto S; Tsubono Y; Sasaki S; Mukai K Mod Pathol; 1999 May; 12(5):492-8. PubMed ID: 10349987 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]